Search

Search Constraints

You searched for: Author/Creator Lock, Richard B.

Search Results

1. Efficacy of CPX‐351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program. Issue 1 (9th September 2014)

3. Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing program. Issue 6 (18th November 2014)

4. Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the pediatric preclinical testing program1. Issue 7 (9th January 2013)

5. Initial testing (stage 1) of the notch inhibitor PF‐03084014, by the pediatric preclinical testing program. Issue 8 (24th March 2014)

6. Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program. Issue 3 (24th November 2015)

7. Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program1. Issue 4 (2nd July 2012)

8. Initial testing of VS‐4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program. Issue 4 (27th October 2016)

9. Optimization of a clofarabine‐based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia. Issue 4 (25th December 2019)

10. Potent antileukemic activity of curaxin CBL0137 against MLL‐rearranged leukemia. Issue 7 (8th August 2019)